A detailed history of Charles Schwab Investment Management Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,269,478 shares of BHC stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,269,478
Previous 1,226,939 3.47%
Holding current value
$10.8 Million
Previous $8.55 Million 20.99%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.22 - $8.26 $222,053 - $351,372
42,539 Added 3.47%
1,269,478 $10.3 Million
Q2 2024

Aug 12, 2024

BUY
$6.1 - $10.41 $7.48 Million - $12.8 Million
1,226,939 New
1,226,939 $8.55 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.